The Indian Competition Authority reviews 15 years of enforcement and merger scrutiny in the pharmaceutical and life sciences sector, targeting trade association cartels, hospital excessive pricing and patent-related dominance concerns
The life sciences and pharmaceutical industry in India is of great significance globally as well as domestically, being the third largest (by volume) in the world. In addition to supplying more than…
Read the full articleYou might also wanna read

Fortune India MPW 2026: India's milk demand is growing faster than supply, says Heritage Foods' Brahmani Nara
Fortune India·18h ago
Petition of CERC (Procedure, Terms and Conditions for Grant of Trading License and other related matters) Regulations of Category V license for Inter-State trading of Electricity in all States and Union Territories of India – EQ
Solar Quarter·18h ago
India Achieves Another Landmark as Clean Energy Powers More Than Half of National Electricity Demand – EQ
Solar Quarter·20h ago
Delhi Reinforces Green Energy Vision with Strong Commitment to Clean and Sustainable Power Transition – EQ
Solar Quarter·20h ago
Kumbalangi Emerges as Front-Runner in Ernakulam’s Vision for Sustainable Solar-Powered Villages – EQ
Solar Quarter·20h ago
Battery Smart Secures Fresh ₹124 Crore Debt to Accelerate Electric Mobility and Battery Swapping Expansion – EQ
Solar Quarter·20h ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.